Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Stock Has Average Price Target of $7.00 According to Brokerages

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Stock Has Average Price Target of $7.00 According to Brokerages

Shares of Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS - Get Free Report) have received an average recommendation of "Moderate Buy" from the five ratings firms that are currently covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation and four hav

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Stock Has Average Price Target of $6.75 According to Brokerages

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) has earned an average recommendation of “Moderate Buy” from the ten ratings firms that are currently covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and six have given a buy rating to the […]